标题
Overcoming multidrug resistance with nanomedicines
作者
关键词
-
出版物
Expert Opinion on Drug Delivery
Volume 12, Issue 2, Pages 223-238
出版商
Informa Healthcare
发表日期
2014-09-16
DOI
10.1517/17425247.2015.960920
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Precision Nanomedicine in Neurodegenerative Diseases
- (2014) Meir Goldsmith et al. ACS Nano
- Nanoparticles for Imaging, Sensing, and Therapeutic Intervention
- (2014) Lara K. Bogart et al. ACS Nano
- Modulation of Drug Resistance in Ovarian Adenocarcinoma Using Chemotherapy Entrapped in Hyaluronan-Grafted Nanoparticle Clusters
- (2014) Keren Cohen et al. ACS Nano
- Precision medicine – Delivering the goods?
- (2014) Dan Peer CANCER LETTERS
- Quaternized starch-based carrier for siRNA delivery: From cellular uptake to gene silencing
- (2014) Eliz Amar-Lewis et al. JOURNAL OF CONTROLLED RELEASE
- Tumor targeting profiling of hyaluronan-coated lipid based-nanoparticles
- (2014) Shoshy Mizrahy et al. Nanoscale
- Codelivery of an Optimal Drug/siRNA Combination Using Mesoporous Silica Nanoparticles To Overcome Drug Resistance in Breast Cancer in Vitro and in Vivo
- (2013) Huan Meng et al. ACS Nano
- Rationally designed nanovehicles to overcome cancer chemoresistance
- (2013) Yoav D. Livney et al. ADVANCED DRUG DELIVERY REVIEWS
- Targeting Multidrug Resistance Protein 1 (MRP1, ABCC1): Past, Present, and Future
- (2013) Susan P.C. Cole Annual Review of Pharmacology and Toxicology
- Omics-based nanomedicine: The future of personalized oncology
- (2013) Daniel Rosenblum et al. CANCER LETTERS
- Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology
- (2013) U. Prabhakar et al. CANCER RESEARCH
- A daunting task: manipulating leukocyte function with RNAi
- (2013) Dan Peer IMMUNOLOGICAL REVIEWS
- RNAi-based nanomedicines for targeted personalized therapy
- (2012) Ala Daka et al. ADVANCED DRUG DELIVERY REVIEWS
- The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
- (2012) Hiroshi Maeda et al. ADVANCED DRUG DELIVERY REVIEWS
- Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine
- (2012) Jeffrey A. Silverman et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Insights on P-Glycoprotein’s Efflux Mechanism Obtained by Molecular Dynamics Simulations
- (2012) Ricardo J. Ferreira et al. Journal of Chemical Theory and Computation
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Polysaccharides as building blocks for nanotherapeutics
- (2011) Shoshy Mizrahy et al. CHEMICAL SOCIETY REVIEWS
- Antibody-Radionuclide Conjugates for Cancer Therapy: Historical Considerations and New Trends
- (2011) M. Steiner et al. CLINICAL CANCER RESEARCH
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
- (2011) A.-P. Magiorakos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance
- (2011) Alina Shapira et al. DRUG RESISTANCE UPDATES
- Mammalian multidrug-resistance proteins (MRPs)
- (2011) Andrew J. Slot et al. Essays in Biochemistry
- Special delivery: targeted therapy with small RNAs
- (2011) D Peer et al. GENE THERAPY
- Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
- (2011) Twan Lammers et al. JOURNAL OF CONTROLLED RELEASE
- Engineered Design of Mesoporous Silica Nanoparticles to Deliver Doxorubicin and P-Glycoprotein siRNA to Overcome Drug Resistance in a Cancer Cell Line
- (2010) Huan Meng et al. ACS Nano
- Role of Transmembrane Segment 5 and Extracellular Loop 3 in the Homodimerization of Human ABCC1
- (2010) Youyun Yang et al. BIOCHEMISTRY
- Paclitaxel-clusters coated with hyaluronan as selective tumor-targeted nanovectors
- (2010) Ilia Rivkin et al. BIOMATERIALS
- The tumour-targeting human L19-IL2 immunocytokine: Preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma
- (2010) Manfred Johannsen et al. EUROPEAN JOURNAL OF CANCER
- Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
- (2010) Mark E. Davis et al. NATURE
- Inhibition of ABCB1 (MDR1) Expression by an siRNA Nanoparticulate Delivery System to Overcome Drug Resistance in Osteosarcoma
- (2010) Michiro Susa et al. PLoS One
- The Human Breast Cancer Resistance Protein (BCRP/ABCG2) Shows Conformational Changes with Mitoxantrone
- (2010) Mark F. Rosenberg et al. STRUCTURE
- In vivo biotinylation of the vasculature in B-cell lymphoma identifies BST-2 as a target for antibody-based therapy
- (2009) C. Schliemann et al. BLOOD
- Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
- (2009) S. G. Aller et al. SCIENCE
- Protein nanoparticles as drug carriers in clinical medicine
- (2008) Michael J. Hawkins et al. ADVANCED DRUG DELIVERY REVIEWS
- Treatment of resistant human colon cancer xenografts by a fluoxetine–doxorubicin combination enhances therapeutic responses comparable to an aggressive bevacizumab regimen
- (2008) Mirit Argov et al. CANCER LETTERS
- A high-affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo-vasculaturein vivo
- (2008) Alessandra Villa et al. INTERNATIONAL JOURNAL OF CANCER
- Receptor targeted polymers, dendrimers, liposomes: Which nanocarrier is the most efficient for tumor-specific treatment and imaging?
- (2008) Maha Saad et al. JOURNAL OF CONTROLLED RELEASE
- Homology modeling of breast cancer resistance protein (ABCG2)
- (2008) Eszter Hazai et al. JOURNAL OF STRUCTURAL BIOLOGY
- Nanoparticle therapeutics: an emerging treatment modality for cancer
- (2008) Mark E. Davis et al. NATURE REVIEWS DRUG DISCOVERY
- Systemic Leukocyte-Directed siRNA Delivery Revealing Cyclin D1 as an Anti-Inflammatory Target
- (2008) D. Peer et al. SCIENCE
- Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition
- (2008) S.-F. Zhou XENOBIOTICA
- Molecular modeling of the human multidrug resistance protein 1 (MRP1/ABCC1)
- (2007) Marianne K. DeGorter et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started